Join the 200th Anniversary Celebration

Original Article

High-Frequency Oscillatory Ventilation versus Conventional Mechanical Ventilation for Very-Low-Birth-Weight Infants

Sherry E. Courtney, M.D., David J. Durand, M.D., Jeanette M. Asselin, R.R.T., M.S., Mark L. Hudak, M.D., Judy L. Aschner, M.D., and Craig T. Shoemaker, M.D. for the Neonatal Ventilation Study Group

N Engl J Med 2002; 347:643-652August 29, 2002

Abstract

Background

The efficacy and safety of early high-frequency oscillatory ventilation as compared with conventional synchronized intermittent mandatory ventilation for the treatment of infants with very low birth weight have not been established.

Methods

We conducted a randomized, multicenter clinical trial to determine whether infants treated with early high-frequency oscillatory ventilation were more likely than infants treated with synchronized intermittent mandatory ventilation to be alive without requiring supplemental oxygen at 36 weeks of postmenstrual age. Eligible infants weighed 601 to 1200 g at birth, were less than four hours of age, had received one dose of surfactant, and required ventilation with a mean airway pressure of at least 6 cm of water and a fraction of inspired oxygen of at least 0.25. Infants were stratified according to birth weight and exposure to prenatal corticosteroids and then randomly assigned to high-frequency oscillatory ventilation or synchronized intermittent mandatory ventilation. Ventilation was managed according to protocols designed to optimize lung inflation and blood gas values.

Results

Five hundred infants were enrolled in the study. Infants randomly assigned to high-frequency oscillatory ventilation were successfully extubated earlier than infants assigned to synchronized intermittent mandatory ventilation (P<0.001). Of infants assigned to high-frequency oscillatory ventilation, 56 percent were alive without a need for supplemental oxygen at 36 weeks of postmenstrual age, as compared with 47 percent of those receiving synchronized intermittent mandatory ventilation (P=0.046). There was no difference between the groups in the risk of intracranial hemorrhage, cystic periventricular leukomalacia, or other complications.

Conclusions

There was a small but significant benefit of high-frequency oscillatory ventilation in terms of the pulmonary outcome for very-low-birth-weight infants without an increase in the occurrence of other complications of premature birth.

Media in This Article

Figure 3Kaplan–Meier Curves Showing Ages at Which Infants Were Successfully Weaned from All Support.
Figure 1Mean (±SD) Airway Pressure during the First Seven Days of Life.
Article

High-frequency oscillatory ventilation delivers small tidal volumes generated by an oscillatory piston or diaphragm at rapid rates, superimposed on a variable mean airway pressure. Multiple studies in animals suggest advantages of high-frequency oscillatory ventilation as compared with conventional ventilation for supporting immature or injured lungs.1-12 However, clinical trials comparing high-frequency oscillatory ventilation with conventional ventilation in infants with very low birth weight have yielded mixed results.13-25 These clinical trials varied widely in design, criteria for entry, the use or nonuse of exogenous surfactant, the strategy for lung recruitment (i.e., inflation), and the types of ventilators studied. Most compared high-frequency oscillatory ventilation with intermittent mandatory ventilation without tidal-volume monitoring. The potential role of high-frequency oscillatory ventilation in the care of very-low-birth-weight infants is further clouded by conflicting data suggesting that the use of such ventilation may be associated with an increased risk of intracranial hemorrhage or cystic periventricular leukomalacia.17,20,23 Thus, despite 20 years of experience with high-frequency oscillatory ventilation, there is no consensus about its role in the care of very-low-birth-weight infants.26

We conducted an investigator-initiated, multicenter, randomized, noncrossover, controlled clinical trial comparing high-frequency oscillatory ventilation with synchronized intermittent mandatory ventilation with continuous tidal-volume monitoring to determine whether early institution of high-frequency oscillatory ventilation would improve the pulmonary outcome of very-low-birth-weight infants without increasing the incidence of intracranial hemorrhage or cystic periventricular leukomalacia.

Methods

All aspects of study design, data collection and analysis, and presentation were under the control of the study's executive committee. Some equipment and funding were provided by industry sponsors, who were otherwise not involved with the protocol.

Study Sites

The trial was conducted at 26 tertiary neonatal intensive care units, including community, university, and children's hospitals. Each site was visited by members of the executive committee before the study began. The institutional review board at each site approved the protocol, and written, informed parental consent was obtained for all enrolled infants.

Eligible Infants

Infants were eligible if they weighed 601 to 1200 g at birth, were appropriately developed for their gestational age, had received one dose of surfactant (Survanta, Ross Products Division, Abbott Laboratories), required conventional mechanical ventilation with a fraction of inspired oxygen (FiO2) of at least 0.25 and a mean airway pressure of at least 6 cm of water, were less than 4 hours of age, and were expected to require mechanical ventilation for more than 24 hours. Infants were not eligible if they had a five-minute Apgar score of 3 or less, a base deficit of 15 or more before study entry, severe hypotension (a systolic blood pressure more than 2 SD below the mean for their birth weight27 despite a total combined dose of dopamine, dobutamine, or both, of 20 μg per kilogram of body weight per minute), obvious chromosomal or congenital anomalies, congenital heart disease, or known neuromuscular disease.

Randomization

Infants were randomly assigned by members of the staff at the clinical coordinating center in Oakland, California, who could be contacted by pager 24 hours a day. Eligible infants were stratified according to birth weight (601 to 700, 701 to 800, 801 to 1000, and 1001 to 1200 g), exposure to antenatal corticosteroids, and study site. All infants received conventional ventilation before enrollment. Infants randomly assigned to high-frequency oscillatory ventilation were immediately switched to high-frequency oscillatory ventilation. Infants assigned to synchronized intermittent mandatory ventilation continued receiving synchronized intermittent mandatory ventilation or were switched to synchronized intermittent mandatory ventilation if necessary. Infants remained in the study until they were discharged from the hospital.

Ventilation Strategies

Infants assigned to high-frequency oscillatory ventilation received ventilation with the SensorMedics 3100A ventilator. Infants assigned to synchronized intermittent mandatory ventilation received ventilation with either the VIP Bird ventilator (Bird Products), the Babylog 8000 (North American Dräger), the Bear Cub Ventilator with attached Neonatal Volume Monitor, or the Bear Cub 750vs (Viasys Health Care). These ventilators provide flow-triggered synchronized intermittent mandatory ventilation and continuous tidal-volume monitoring at the hub (connection) of the endotracheal tube. For all infants assigned to synchronized intermittent mandatory ventilation, the assist sensitivity was set at 0.2 liter per minute; the VIP Bird termination-sensitivity option was not used.

The ventilation strategies and study protocol were tested and refined in a pilot study.28 Strategies for ventilation for both groups emphasized lung recruitment (i.e., inflation) and avoidance of atelectasis and overdistention. We defined ideal lung inflation as expansion to 8 to 9.5 ribs for most infants (the top of the right hemidiaphragm relative to the posterior ribs on chest radiography at full inspiration), but 7 to 8 ribs for infants with air leak or chronic lung disease. For infants assigned to high-frequency oscillatory ventilation, the initial mean airway pressure was at least 2 cm of water higher than that received during conventional ventilation; the inspiratory:expiratory ratio was 0.33 and the frequency was 10 to 15 Hz. For infants assigned to synchronized intermittent mandatory ventilation, expiratory tidal volumes of 4 to 7 ml per kilogram of body weight were allowed, with a preferred target range of 5 to 6 ml per kilogram. The end expiratory pressure began at 4 to 6 cm of water, depending on the FiO2 and lung inflation. Inspiratory times of 0.25 to 0.40 second were allowed, with rates not to exceed 60 breaths per minute.

The protocol dictated maintenance of arterial oxygen saturation, as measured by pulse oximetry, between 88 and 96 percent, an arterial pH of at least 7.20, and moderate permissive hypercapnia with a partial pressure of carbon dioxide (PCO2) of 40 to 55 mm Hg. For infants with chronic lung disease, air-leak syndromes, or persistent hyperinflation, the target PCO2 was 45 to 65 mm Hg.

The ventilation protocols included aggressive weaning if blood gases and lung inflation (as indicated by chest radiographs) remained within target ranges. At a minimum, assessments of blood gases were made 20 minutes after study entry, every 20 to 30 minutes until target ranges were achieved, then every 4 hours for 24 hours, every 6 hours from hours 25 to 72, and then daily until the infant was extubated and had not received nasal continuous positive airway pressure for three days. At a minimum, chest radiography was performed in infants assigned to high-frequency oscillatory ventilation at 1 to 2 hours, 4 to 6 hours, and 24 hours after study entry and then daily for 7 days or until extubation; for infants assigned to synchronized intermittent mandatory ventilation, radiographs were obtained daily for 3 days and then at 5 to 7 days if the infant was still receiving ventilation. Changes in ventilator settings were required if the criteria for target blood gas values and lung inflation were not met.28 For infants receiving high-frequency oscillatory ventilation, these included an increased mean airway pressure for an FiO2 greater than 0.40 and changes in amplitude to keep the PCO2 within target ranges. For infants receiving synchronized intermittent mandatory ventilation, these included strict attention to expiratory tidal volume, with adjustments in end-expiratory pressure based on lung inflation and in rate based on the PCO2. For critically ill infants who could not be oxygenated or receive ventilation according to the protocol, clear exit criteria allowed treatment with alternative modes of ventilation. Such infants remained in the study and were analyzed according to their initial assignment. All other infants continued to receive ventilation according to their assigned mode until death or successful extubation.

Extubation was required when infants' condition had been stable for 6 to 12 hours while they were receiving minimal ventilatory support (for synchronized intermittent mandatory ventilation, the FiO2 was no more than 0.25 and mean airway pressure was no more than 5 cm of water; for high-frequency oscillatory ventilation, the FiO2 was no more than 0.25 and mean airway pressure was no more than 7 cm of water). The difference of 2 cm of water in mean airway pressure was intentional, since the flow characteristics of the SensorMedics ventilator at 33 percent inspiratory time result in an alveolar mean airway pressure 1 to 2 cm of water below that recorded at the hub of the endotracheal tube.29,30

All infants were treated with caffeine or theophylline before extubation. When extubated, all infants were placed on nasal continuous positive airway pressure (Infant Flow, Electro Medical Equipment) and then weaned to a nasal cannula or room air. Infants for whom extubation failed because of inadequate oxygenation, inadequate ventilation, or severe apnea were placed back on their originally assigned ventilator.

Medical Treatment

All infants were treated with surfactant before study entry. Second and third doses were required if infants remained intubated with an FiO2 of at least 0.30 6 to 12 hours after the previous dose. A fourth dose could be given at the discretion of the attending neonatologist. Surfactant was administered with use of in-line catheters (Trach Care Mac Multi-Access Catheter, Ballard Medical Products). Suctioning was performed only as needed, with the use of an in-line suction catheter (Trach Care Neonatal Closed Tracheal Suction System, Ballard Medical Products). Ventilation continued during the administration of surfactant and suctioning.

All infants received prophylactic indomethacin.31 Infants in whom patent ductus arteriosus subsequently developed were treated with additional indomethacin or surgical ligation.

Protocols delineated the use of dexamethasone, diuretics, and bronchodilators for the treatment of chronic lung disease. Infants who were more than 7 days of age and ventilated with an FiO2 of at least 0.40 or who were more than 21 days of age and ventilated with an FiO2 of at least 0.30 received dexamethasone (initial dose, 0.3 mg per kilogram per day, tapered over a period of 12 days). Infants who had completed a course of dexamethasone but who were still dependent on a ventilator with an FiO2 of at least 0.30 were treated again with dexamethasone after a five-day hiatus. Infants more than 21 days old who were receiving dexamethasone and who were still ventilated with an FiO2 greater than 0.40 were treated with diuretics. Bronchodilator therapy was allowed, but not required, for infants more than 14 days of age who were receiving dexamethasone and were ventilated with an FiO2 greater than 0.40. Infants were screened for hearing loss at 34 to 36 weeks of postmenstrual age with the use of auditory brain-stem response testing (ALGO 2 or ALGO 2e, Natus Medical).

Respiratory Outcomes

The a priori primary null hypothesis was that there would be no difference between the two groups in the number of infants who were alive and did not require supplemental oxygen at 36 weeks of postmenstrual age. We carefully assessed the need for oxygen at 36 weeks by giving all infants still receiving oxygen a trial with room air. If at any time during the 24-hour evaluation period the infant required oxygen to maintain a partial oxygen saturation greater than 87 percent, the infant was considered to be dependent on oxygen. Successful extubation was defined a priori as occurring when an infant remained extubated for at least two weeks.

Assessment of Intracranial Hemorrhage, Cystic Periventricular Leukomalacia, and Other Clinical Outcomes

Cranial ultrasonography was performed between days 7 and 10, 21 and 30, and 50 and 60. Ultrasonograms were scored by both a radiologist at the site and the primary reviewer, who was unaware of the infant's study-group assignment, with the use of a standardized scoring sheet developed for the study. Intracranial hemorrhage was graded according to severity from I to IV, with higher numbers indicating more severe disease.32 The ultrasonographic evaluations were then reviewed by one of the principal investigators. Discrepancies in interpretation between the site radiologist and the masked reviewer were resolved by a second reviewer who was unaware of both the study-group assignment and the previous interpretations. Other outcomes were based on the diagnoses of the treating physicians.

Monitoring

Sites were monitored by means of site visits, weekly telephone calls, and reviews of the respiratory-care flow sheets from each study day. We calculated study compliance by dividing the time infants received ventilation into six-hour periods and assessing whether the ventilation protocols were followed during each of those periods.

Statistical Analysis

The study was based on the assumptions that 50 percent of the study population would be alive and not requiring supplemental oxygen at 36 weeks of postmenstrual age33-35 and that assignment to high-frequency oscillatory ventilation would result in a clinically important improvement in this outcome to 65 percent. Using a two-tailed alpha error of 0.05, a beta error of 0.10 (power of 90 percent), and — on the basis of the pilot study28 — assuming a 6 percent rate of withdrawal and a 10 percent incidence of twins and triplets, we calculated the sample size to be 500.

Analyses were performed according to the intention-to-treat principle, with all patients included who could be evaluated. Categorical outcomes were compared with use of Fisher's exact test. Normally distributed continuous outcomes were compared with use of the unpaired Student's t-test, and nonparametric continuous outcomes with use of the Wilcoxon rank-sum test or the Mann–Whitney U test. Serial data were compared with use of a repeated-measures analysis of variance. All analyses were conducted with two-tailed tests. Time-based analyses of age at extubation and age at the time the infant was weaned to room air are presented as Kaplan–Meier curves with Cox proportional-hazards estimates. The statistical software used included Instat (GraphPad Software) and SAS (SAS Institute).

Results

Characteristics at Base Line

Between July 1998 and May 2000, 2226 infants who weighed 601 to 1200 g at birth were admitted to the study sites. Of these, 895 met the criteria for entry; 87 of these were not enrolled because of the unavailability of equipment, the parents of 158 refused consent, and no attempt was made to obtain consent for 150 infants. The remaining 500 infants were enrolled (245 were assigned to high-frequency oscillatory ventilation and 255 to synchronized intermittent mandatory ventilation). Two infants with late-diagnosed congenital heart disease were subsequently excluded. Analyses were performed on the remaining 244 infants assigned to high-frequency oscillatory ventilation and the 254 assigned to synchronized intermittent mandatory ventilation. Fourteen infants (2.8 percent of the total study population of 500) were withdrawn by parental request (10 assigned to high-frequency oscillatory ventilation and 4 assigned to synchronized intermittent mandatory ventilation). Data on these infants were included in the analyses up to the time of their withdrawal. The characteristics of both groups at study entry are presented in Table 1Table 1Characteristics of Infants at Study Entry..

Ventilatory Support

During the first seven days, infants assigned to high-frequency oscillatory ventilation, as expected, received ventilation with a higher mean airway pressure (P<0.001) (Figure 1Figure 1Mean (±SD) Airway Pressure during the First Seven Days of Life.). The mean FiO2 was slightly higher in those assigned to high-frequency oscillatory ventilation (37 to 41 mm Hg, as compared with 30 to 36 mm Hg in those assigned to synchronized intermittent mandatory ventilation; P=0.01), but there was no significant difference between the groups in the mean partial oxygen saturation (P=0.62). Overall, the mean PCO2 values were slightly lower in infants assigned to high-frequency oscillatory ventilation (43 to 48 mm Hg, as compared with 43 to 50 mm Hg in those assigned to synchronized intermittent mandatory ventilation; P<0.001); however, the PCO2 remained within the target ranges in both treatment groups.

Outcome

As shown in Figure 2Figure 2Kaplan–Meier Curves Showing Ages at Which Infants Were Successfully Extubated., the age at successful extubation was significantly lower for infants assigned to high-frequency oscillatory ventilation than for those assigned to synchronized intermittent mandatory ventilation (P<0.001). More infants assigned to high-frequency oscillatory ventilation were alive without requiring supplemental oxygen at 36 weeks of postmenstrual age (131 vs. 117 [56 percent vs. 47 percent]; relative risk, 1.2 [95 percent confidence interval, 1.0 to 1.5]; P=0.046) (Table 2Table 2Respiratory Outcomes.). In addition to the status at 36 weeks, the a priori outcome for which the statistical power of the study was designed, we evaluated the proportion of infants alive and not receiving any respiratory or oxygen support over time (Kaplan–Meier analysis) (Figure 3Figure 3Kaplan–Meier Curves Showing Ages at Which Infants Were Successfully Weaned from All Support.). Major complications of prematurity are shown in Table 3Table 3Clinical Outcomes.. There were no significant differences in the incidence of intracranial hemorrhage, severe intracranial hemorrhage (grade III or IV), cystic periventricular leukomalacia, or combined severe intracranial hemorrhage and cystic periventricular leukomalacia. There were also no significant differences in the incidence of patent ductus arteriosus, pneumothorax, necrotizing enterocolitis, intestinal perforation, sepsis, retinopathy of prematurity, or hearing loss before discharge. Pulmonary hemorrhage was less likely to develop (P=0.015) and pulmonary interstitial emphysema was slightly more likely to develop in infants assigned to high-frequency oscillatory ventilation (P=0.052). Pulmonary interstitial emphysema and pulmonary hemorrhage were not prospectively defined, and these differences must be interpreted with caution.

Pharmacologic treatment in the two groups is shown in Table 4Table 4Pharmacologic Treatment.. Slightly more infants assigned to synchronized intermittent mandatory ventilation received only one dose of surfactant (P=0.046). Bronchodilators were used in fewer infants assigned to high-frequency oscillatory ventilation (P=0.006). The rate of compliance with the study protocol was 86 percent in infants assigned to high-frequency oscillatory ventilation and 87 percent in infants assigned to synchronized intermittent mandatory ventilation.

Discussion

Infants treated with high-frequency oscillatory ventilation were successfully extubated earlier and were more likely than those treated with synchronized intermittent mandatory ventilation to be alive without requiring supplemental oxygen at 36 weeks of postmenstrual age. For every 11 infants treated with high-frequency oscillatory ventilation, 1 death or case of chronic lung disease was prevented (absolute reduction in risk, 9.2 percent). These results confirm the findings of multiple studies in animals that have demonstrated the superiority of high-frequency oscillatory ventilation to conventional ventilation.1-12 They also confirm the results of Gerstmann et al. in a study of infants of higher birth weight.21

In 1989, the HIFI Study Group reported that high-frequency oscillatory ventilation failed to improve respiratory outcomes and perhaps increased the likelihood of severe intracranial hemorrhage and cystic periventricular leukomalacia.20 Since that time, many changes have occurred in both neonatal care and ventilation strategies. Surfactant replacement has become a routine treatment, and more is known about the importance of optimal lung recruitment during high-frequency ventilation4,36-41 and about the importance of monitoring and controlling tidal volume during conventional ventilation.42-45 The smaller trials of high-frequency ventilation that followed the HIFI study yielded conflicting results. These trials varied widely in criteria for entry and methods.13-19,21-25 Some studies were undertaken before the introduction of surfactant-replacement therapy17,19 or employed high-frequency devices not currently used in the United States.22,23 Other trials did not consistently use a lung-recruitment strategy16 or studied relatively mature preterm infants.21 Most studies compared high-frequency ventilation with nonsynchronized intermittent mandatory ventilation.17-19,21,22,24,25

We designed this trial to compare high-frequency oscillatory ventilation with a type of synchronized intermittent mandatory ventilation in which both breath-triggering and tidal-volume monitoring occurred at the airway.46 We chose to compare high-frequency oscillatory ventilation with synchronized intermittent mandatory ventilation because several studies suggest improved pulmonary outcomes with synchronized intermittent mandatory ventilation as compared with nonsynchronized ventilator breathing.44,47-51 We chose a narrow range of tidal volumes on the basis of data from studies in both animals and humans, which suggested that lower tidal volumes decrease volutrauma.42,43,52 Our management protocols for high-frequency oscillatory ventilation and synchronized intermittent mandatory ventilation were designed to optimize lung recruitment and avoid maneuvers that could lead to derecruitment. Lung recruitment has been demonstrated to be important for optimal outcome with high-frequency oscillatory ventilation.4,7,9,36-38,40,41 Given that the FiO2 was slightly higher in the infants assigned to high-frequency oscillatory ventilation during the first week, it is possible that even better recruitment could have been accomplished.53 Nonetheless, we found that high-frequency oscillatory ventilation used with this strategy significantly improved respiratory outcome in this population.

Although the HIFI trial suggested that high-frequency oscillatory ventilation increased the incidence of intracranial hemorrhage and cystic periventricular leukomalacia,20 other studies have yielded conflicting results.17,19,21,23 Our large study found no difference in the incidence of intracranial hemorrhage or cystic periventricular leukomalacia, findings consistent with the results of a prior meta-analysis.53 The incidence of severe intracranial hemorrhage in our study was similar to that seen in other studies.54,55 The incidence of cystic periventricular leukomalacia in both the infants assigned to high-frequency oscillatory ventilation and those assigned to synchronized intermittent mandatory ventilation was higher than some published rates,56 probably because cystic periventricular leukomalacia may be missed if cranial ultrasonography is not performed six to eight weeks after birth.57-59 Half of the cases of cystic periventricular leukomalacia in our study subjects were diagnosed at the time of the third cranial ultrasound examination.

We believe that the marked decrease in the number of days before successful extubation and the increase in the number of infants who survived without chronic lung disease in the group assigned to high-frequency oscillatory ventilation suggest that high-frequency oscillatory ventilation offers a small but significant benefit at experienced centers and, in such settings, should be considered the first line of ventilatory support in this group of very preterm infants.

Supported in part by grants from Ross Products Division, Abbott Laboratories; SensorMedics; Ballard Medical Products; Natus Medical; Electro Medical Equipment; and the Society for Pediatric Research.

We are indebted to members of the Data Safety and Monitoring Committee: Reese H. Clark, M.D. (chairman), Mark Mammel, M.D., Jim Ashurst, Ph.D., and Jeff Burns, M.D.; to the masked reviewers of the ultrasonographic data: Daniel A. Merton, R.D., M.S., and Archie Alexander, M.D.; to Mark Espeland, Ph.D., Lin Gu, M.S., Darrin Harris, B.S., and the Department of Public Health Sciences at Wake Forest University School of Medicine for help with data management and statistical analysis; to the Wake Forest University School of Medicine General Clinical Research Center for its support of this study at North Carolina Baptist Medical Center and Forsyth Medical Center in Winston-Salem, N.C.; to Coastal Area Health Education Center for its support of this study at New Hanover Regional Medical Center in Wilmington, N.C.; to Clinical Trials Management of Spartanburg Regional Medical Center in Spartanburg, S.C.; to Lori Pacello, R.T., for her tireless efforts in study coordination and administration; to Joanne Gloway for administrative assistance; to the many nurses and respiratory therapists at the study sites who helped collect data and maintain compliance with the protocol; and, most especially, to the families and infants who participated in this study.

Source Information

From the Division of Neonatology, Cooper Hospital–University Medical Center, Camden, N.J. (S.E.C.); the Division of Neonatology (D.J.D.) and the Neonatal–Pediatric Research Group (J.M.A.), Children's Hospital and Research Center at Oakland, Oakland, Calif.; the Division of Neonatology, University of Florida at Jacksonville, and the Division of Neonatology, Wolfson Children's Hospital, Jacksonville, Fla. (M.L.H.); the Division of Neonatology, Wake Forest University School of Medicine, Winston-Salem, N.C. (J.L.A.); and MeritCare Children's Hospital, Fargo, N.D. (C.T.S.).

Address reprint requests to Dr. Courtney at the Division of Neonatology, Schneider Children's Hospital, Long Island Jewish Medical Center, 270-05 76th Ave., New Hyde Park, NY 11040, or at .

Other members of the Neonatal Ventilation Study Group are listed in the Appendix.

Appendix

Members of the executive committee were S.E. Courtney, D.J. Durand, and J.M. Asselin. The following institutions and investigators participated in the Neonatal Ventilation Study Group: Albany Medical Center, Albany, N.Y. — M. Fisher, P. Graziano, and S. Boynton; Children's Hospital Oakland, Oakland, Calif. — L. Jurcisin; Children's Hospital of Orange County, Orange, Calif. — J. Cleary and E. Drake; City Avenue Hospital, Philadelphia — K. Solarin, D. Miller, and S. Vagelaras; Cooper Hospital–University Medical Center, Camden, N.J. — J. Saslow and J. Hart; Crouse Hospital, Syracuse, N.Y. — T. Curran and P. Parker; Geisinger Medical Center, Danville, Pa. — J. Cook and J. Conrad; Louisiana State University Medical Center, Shreveport — A. Pramanik and J. Loggins; Kosair Children's Hospital, University of Louisville School of Medicine, Louisville, Ky. — D.L. Stewart and A. Hilbert; MeritCare Medical Center, Fargo, N.D. — V. Fearing; New Hanover Regional Medical Center, Wilmington, N.C. — R. McArtor, S. Sachariat, B. Justason, and J. Check; Ochsner Foundation Hospital, New Orleans — H. Ginsberg, W. Quinn, and L. Kimble; Saint Francis Medical Center, Monroe, La. — M. deSolar, D. Wood, and M. Wooten; Saint Joseph's Hospital, Phoenix, Ariz. — M. Hart and E. Ranthum; Parkview Memorial Hospital, Fort Wayne, Ind. — I. Bilyk and C. Quackenbush; Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, N.Y. — A. Steele and B. Wilkens; Spartanburg Regional Medical Center, Spartanburg, S.C. — V. Iskersky and B. McKown; University of California at Irvine, Irvine — B. Govindaswami, C. Uy, J. Denson, and S. Kusano; University of Connecticut Health Center, Farmington — M. Pappagallo, M. Holman, R. Arens, and K. Jennings; University Medical Center at Stony Brook, Stony Brook, N.Y., and Westchester Medical Center, Valhalla, N.Y. — L. Parton, A. Rohan, and N. Dweck; Wake Forest University School of Medicine (North Carolina Baptist Medical Center and Forsyth Medical Center), Winston-Salem, N.C. — M. Fuloria and B.J. Hansell; Women's and Children's Hospital and the Hospital of the Good Samaritan, Los Angeles — R. Ramanathan, R. Erickson, H. Chinchilla, and K. Scott; Shands Jacksonville, Wolfson Children's Hospital, and the University of Florida Health Science Center, Jacksonville — E. Case and A. Kellum.

References

References

  1. 1

    Simma B, Luz G, Trawoger R, et al. Comparison of different modes of high-frequency ventilation in surfactant-deficient rabbits. Pediatr Pulmonol 1996;22:263-270
    CrossRef | Web of Science | Medline

  2. 2

    Yoder BA, Siler-Khodr T, Winter VT, Coalson JJ. High-frequency oscillatory ventilation: effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease. Am J Respir Crit Care Med 2000;162:1867-1876
    Web of Science | Medline

  3. 3

    Jackson JC, Truog WE, Standaert TA, et al. Reduction in lung injury after combined surfactant and high-frequency ventilation. Am J Respir Crit Care Med 1994;150:534-539
    Web of Science | Medline

  4. 4

    Froese AB, McCulloch PR, Sugiura M, Vaclavik S, Possmayer F, Moller F. Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit. Am Rev Respir Dis 1993;148:569-577
    CrossRef | Web of Science | Medline

  5. 5

    Meredith KS, deLemos RA, Coalson JJ, et al. Role of lung injury in the pathogenesis of hyaline membrane disease in premature baboons. J Appl Physiol 1989;66:2150-2158
    Web of Science | Medline

  6. 6

    Kinsella JP, Gerstmann DR, Clark RH, et al. High-frequency oscillatory ventilation versus intermittent mandatory ventilation: early hemodynamic effects in the premature baboon with hyaline membrane disease. Pediatr Res 1991;29:160-166
    CrossRef | Web of Science | Medline

  7. 7

    Suzuki H, Papazoglou K, Bryan AC. Relationship between PaO2 and lung volume during high frequency oscillatory ventilation. Acta Paediatr Jpn 1992;34:494-500
    Medline

  8. 8

    deLemos RA, Coalson JJ, Meredith KS, Gerstmann DR, Null DM. A comparison of ventilation strategies for the use of high-frequency oscillatory ventilation in the treatment of hyaline membrane disease. Acta Anaesthesiol Scand Suppl 1989;90:102-107
    CrossRef | Medline

  9. 9

    McCulloch PR, Forkert PG, Froese AB. Lung volume maintenance prevents lung injury during high frequency oscillatory ventilation in surfactant-deficient rabbits. Am Rev Respir Dis 1988;137:1185-1192
    Web of Science | Medline

  10. 10

    deLemos RA, Coalson JJ, Gerstmann DR, et al. Ventilatory management of infant baboons with hyaline membrane disease: the use of high frequency ventilation. Pediatr Res 1987;21:594-602
    CrossRef | Web of Science | Medline

  11. 11

    Hamilton PP, Onayemi A, Smyth JA, et al. Comparison of conventional and high-frequency ventilation: oxygenation and lung pathology. J Appl Physiol 1983;55:131-138
    Web of Science | Medline

  12. 12

    Truog WE, Standaert TA, Murphy JH, Woodrum DE, Hodson WA. Effect of prolonged high-frequency oscillatory ventilation in premature primates with experimental hyaline membrane disease. Am Rev Respir Dis 1984;130:76-80
    Web of Science | Medline

  13. 13

    Pardou A, Vermeylen D, Muller MF, Detemmerman D. High-frequency ventilation and conventional mechanical ventilation in newborn babies with respiratory distress syndrome: a prospective, randomized trial. Intensive Care Med 1993;19:406-410
    CrossRef | Web of Science | Medline

  14. 14

    Keszler M, Modanlou HD, Brudno DS, et al. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome. Pediatrics 1997;100:593-599
    CrossRef | Web of Science | Medline

  15. 15

    Keszler M, Donn SM, Bucciarelli RL, et al. Multicenter controlled trial comparing high-frequency jet ventilation and conventional mechanical ventilation in newborn infants with pulmonary interstitial emphysema. J Pediatr 1991;119:85-93
    CrossRef | Web of Science | Medline

  16. 16

    Patel CA, Klein JM. Outcome of infants with birth weights less than 1000 g with respiratory distress syndrome treated with high-frequency ventilation and surfactant replacement therapy. Arch Pediatr Adolesc Med 1995;149:317-321
    Web of Science | Medline

  17. 17

    HiFO Study Group. Randomized study of high-frequency oscillatory ventilation in infants with severe respiratory distress syndrome. J Pediatr 1993;122:609-619
    CrossRef | Web of Science | Medline

  18. 18

    Plavka R, Kopecky P, Sebron V, Svihovec P, Zlatohlavkova B, Janus V. A prospective randomized comparison of conventional mechanical ventilation and very early high frequency oscillatory ventilation in extremely premature newborns with respiratory distress syndrome. Intensive Care Med 1999;25:68-75
    CrossRef | Web of Science | Medline

  19. 19

    Clark RH, Gerstmann DR, Null DM Jr, deLemos RA. Prospective randomized comparison of high-frequency oscillatory and conventional ventilation in respiratory distress syndrome. Pediatrics 1992;89:5-12
    Web of Science | Medline

  20. 20

    The HIFI Study Group. High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. N Engl J Med 1989;320:88-93
    Full Text | Web of Science | Medline

  21. 21

    Gerstmann DR, Minton SD, Stoddard RA, et al. The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome. Pediatrics 1996;98:1044-1057
    Web of Science | Medline

  22. 22

    Ogawa Y, Miyasaka K, Kawano T, et al. A multicenter randomized trial of high frequency oscillatory ventilation as compared with conventional mechanical ventilation in preterm infants with respiratory failure. Early Hum Dev 1993;32:1-10
    CrossRef | Web of Science | Medline

  23. 23

    Moriette G, Paris-Llado J, Walti H, et al. Prospective randomized multicenter comparison of high-frequency oscillatory ventilation and conventional ventilation in preterm infants of less than 30 weeks with respiratory distress syndrome. Pediatrics 2001;107:363-372
    CrossRef | Web of Science | Medline

  24. 24

    Thome U, Kossel H, Lipowsky G, et al. Randomized comparison of high-frequency ventilation with high-rate intermittent positive pressure ventilation in preterm infants with respiratory failure. J Pediatr 1999;135:39-46
    CrossRef | Web of Science | Medline

  25. 25

    Rimensberger PC, Beghetti M, Hanquinet S, Berner M. First intention high-frequency oscillation with early lung volume optimization improves pulmonary outcome in very low birth weight infants with respiratory distress syndrome. Pediatrics 2000;105:1202-1208
    CrossRef | Web of Science | Medline

  26. 26

    Bhuta T, Henderson-Smart DJ. Elective high-frequency oscillatory ventilation versus conventional ventilation in preterm infants with pulmonary dysfunction: systematic review and meta-analyses. Pediatrics 1997;100:e6-e6
    CrossRef | Web of Science | Medline

  27. 27

    Zubrow AB, Hulman S, Kushner H, Falkner B, Philadelphia Neonatal Blood Pressure Study Group. Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study.J Perinatol 1995;15:470-9.

  28. 28

    Durand DJ, Asselin JM, Hudak ML, et al. Early high-frequency oscillatory ventilation versus synchronized intermittent mandatory ventilation in very low birth weight infants: a pilot study of two ventilation protocols. J Perinatol 2001;21:221-229
    CrossRef | Medline

  29. 29

    Gerstmann DR, Fouke JM, Winter DC, Taylor AF, deLemos RA. Proximal, tracheal, and alveolar pressures during high-frequency oscillatory ventilation in a normal rabbit model. Pediatr Res 1990;28:367-373
    CrossRef | Web of Science | Medline

  30. 30

    Pillow JJ, Neil H, Wilkinson MH, Ramsden CA. Effect of I/E ratio on mean alveolar pressure during high-frequency oscillatory ventilation. J Appl Physiol 1999;87:407-414
    Web of Science | Medline

  31. 31

    Ment LR, Oh W, Ehrenkranz RA, et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994;93:543-550
    Web of Science | Medline

  32. 32

    Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of the subependymal intraventricular hemorrhage: a study of infants with weights less than 1,500 g. J Pediatr 1978;92:529-534
    CrossRef | Web of Science | Medline

  33. 33

    Stevenson DK, Wright LL, Lemons JA, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol 1998;179:1632-1639
    CrossRef | Web of Science | Medline

  34. 34

    Horbar JD, Carpenter JH. Vermont Oxford Network 1999 database summary. Burlington, Vt.: Vermont Oxford Network, 2000.

  35. 35

    Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995;126:605-610
    CrossRef | Web of Science | Medline

  36. 36

    Froese AB. Role of lung volume in lung injury: HFO in the atelectasis-prone lung. Acta Anaesthesiol Scand Suppl 1989;90:126-130
    CrossRef | Medline

  37. 37

    Clark RH, Slutsky AS, Gerstmann DR. Lung protective strategies of ventilation in the neonate: what are they? Pediatrics 2000;105:112-114
    CrossRef | Web of Science | Medline

  38. 38

    Froese AB. High-frequency oscillatory ventilation for adult respiratory distress syndrome: let's get it right this time! Crit Care Med 1997;25:906-908
    CrossRef | Web of Science | Medline

  39. 39

    Bryan AC, Froese AB. Reflections on the HIFI trial. Pediatrics 1991;87:565-567
    Web of Science | Medline

  40. 40

    Boynton BR, Villanueva D, Hammond MD, Vreeland PN, Buckley B, Frantz ID III. Effect of mean airway pressure on gas exchange during high-frequency oscillatory ventilation. J Appl Physiol 1991;70:701-707
    Web of Science | Medline

  41. 41

    Bryan AC, Slutsky AS. Lung volume during high frequency oscillation. Am Rev Respir Dis 1986;133:928-930
    Web of Science | Medline

  42. 42

    Wada K, Jobe AH, Ikegami M. Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs. J Appl Physiol 1997;83:1054-1061
    Web of Science | Medline

  43. 43

    The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308
    Full Text | Web of Science | Medline

  44. 44

    Bernstein G, Heldt GP, Mannino FL. Increased and more consistent tidal volumes during synchronized intermittent mandatory ventilation in newborn infants. Am J Respir Crit Care Med 1994;150:1444-1448
    Web of Science | Medline

  45. 45

    Hershenson MB, Wylam ME. High-frequency ventilation versus conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 1995;23:1443-1445
    CrossRef | Web of Science | Medline

  46. 46

    Cannon ML, Cornell J, Tripp-Hamel DS, et al. Tidal volumes for ventilated infants should be determined with a pneumotachometer placed at the endotracheal tube. Am J Respir Crit Care Med 2000;162:2109-2112
    Web of Science | Medline

  47. 47

    Cleary JP, Bernstein G, Mannino FL, Heldt GP. Improved oxygenation during synchronized intermittent mandatory ventilation in neonates with respiratory distress syndrome: a randomized, crossover study. J Pediatr 1995;126:407-411
    CrossRef | Web of Science | Medline

  48. 48

    Chan V, Greenough A. Randomised controlled trial of weaning by patient triggered ventilation or conventional ventilation. Eur J Pediatr 1993;152:51-54
    CrossRef | Web of Science | Medline

  49. 49

    Greenough A, Hird MF, Chan V. Airway pressure triggered ventilation for preterm neonates. J Perinat Med 1991;19:471-476
    CrossRef | Web of Science | Medline

  50. 50

    Amitay M, Etches PC, Finer NN, Maidens JM. Synchronous mechanical ventilation of the neonate with respiratory distress. Crit Care Med 1993;21:118-124
    CrossRef | Web of Science | Medline

  51. 51

    Bernstein G, Mannino FL, Heldt GP, et al. Randomized multicenter trial comparing synchronized and conventional intermittent mandatory ventilation in neonates. J Pediatr 1996;128:453-463
    CrossRef | Web of Science | Medline

  52. 52

    Ito Y, Manwell SEE, Kerr CL, et al. Effects of ventilation strategies on the efficacy of exogenous surfactant therapy in a rabbit model of acute lung injury. Am J Respir Crit Care Med 1998;157:149-155
    Web of Science | Medline

  53. 53

    Kalenga M, Battisti O, Francois A, Langhendries J-P, Gerstmann DR, Bertrand J-M. High-frequency oscillatory ventilation in neonatal RDS: initial volume optimization and respiratory mechanics. J Appl Physiol 1998;84:1174-1177
    CrossRef | Web of Science | Medline

  54. 54

    Clark RH, Dykes FD, Bachman TE, Ashurst JT. Intraventricular hemorrhage and high-frequency ventilation: a meta-analysis of prospective clinical trials. Pediatrics 1996;98:1058-1061
    Web of Science | Medline

  55. 55

    Claris O, Besnier S, Lapillonne A, Picaud JC, Salle BL. Incidence of ischemic-hemorrhagic cerebral lesions in premature infants of gestational age ≤28 weeks: a prospective ultrasound study. Biol Neonate 1996;70:29-34
    CrossRef | Medline

  56. 56

    Synnes AR, Chien LY, Peliowski A, Baboolal R, Lee SK, Canadian NICU Network. Variations in intraventricular hemorrhage incidence rates among Canadian neonatal intensive care units. J Pediatr 2001;138:525-531
    CrossRef | Web of Science | Medline

  57. 57

    Perlman JM, Risser R, Broyles RS. Bilateral cystic periventricular leukomalacia in the premature infant: associated risk factors. Pediatrics 1996;97:822-827
    Web of Science | Medline

  58. 58

    Goetz MC, Gretebeck RJ, Oh KS, Shaffer D, Hermansen MC. Incidence, timing, and follow-up of periventricular leukomalacia. Am J Perinatol 1995;12:325-327
    CrossRef | Web of Science | Medline

  59. 59

    Pierrat V, Duquennoy C, van Haastert IC, Ernst M, Guilley N, de Vries LS. Ultrasound diagnosis and neurodevelopmental outcome of localised and extensive cystic periventricular leucomalacia. Arch Dis Child Fetal Neonatal Ed 2001;84:F151-F156
    CrossRef | Web of Science | Medline

Citing Articles (98)

Citing Articles

  1. 1

    Roberta L. Keller, Roberta A. Ballard. 2012. Bronchopulmonary Dysplasia. , 658-671.
    CrossRef

  2. 2

    Eric C. Eichenwald. 2012. Care of the Extremely Low-Birthweight Infant. , 390-404.
    CrossRef

  3. 3

    Eduardo Bancalari, Nelson Claure. 2012. Principles of Respiratory Monitoring and Therapy. , 612-632.
    CrossRef

  4. 4

    Joan Balcells. (2012) High-frequency Oscillatory Ventilation From Basics to Evidence, From Evidence to Bedside. Clinical Pulmonary Medicine 19:1, 27-33
    CrossRef

  5. 5

    Peter C. Rimensberger. (2012) The utility of comparing “like with like” in small randomized controlled trials. Pediatric Critical Care Medicine 13:1, 104-106
    CrossRef

  6. 6

    Terence Ip, Sangeeta Mehta. (2011) The role of high-frequency oscillatory ventilation in the treatment of acute respiratory failure in adults. Current Opinion in Critical Care1
    CrossRef

  7. 7

    Sammy Ali, Niall D. Ferguson. (2011) High-Frequency Oscillatory Ventilation in ALI/ARDS. Critical Care Clinics 27:3, 487-499
    CrossRef

  8. 8

    Jan Florian Heuer, Philip Sauter, Jürgen Barwing, Peter Herrmann, Thomas A. Crozier, Annalen Bleckmann, Tim Beißbarth, Onnen Moerer, Michael Quintel. (2011) Effects of High-frequency Oscillatory Ventilation on Systemic and Cerebral Hemodynamics and Tissue Oxygenation: An Experimental Study in Pigs. Neurocritical Care
    CrossRef

  9. 9

    Inéz Frerichs, Ute Achtzehn, Andreas Pechmann, Sven Pulletz, Ernst W. Schmidt, Michael Quintel, Norbert Weiler. (2011) High-frequency oscillatory ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease. Journal of Critical Care
    CrossRef

  10. 10

    Susan W. Aucott. (2011) Bronchopulmonary Dysplasia: Development and Progression in the Neonatal Intensive Care Unit. Pediatric Allergy, Immunology, and Pulmonology 24:2, 113-118
    CrossRef

  11. 11

    Jason Gien, John P Kinsella. (2011) Pathogenesis and treatment of bronchopulmonary dysplasia. Current Opinion in Pediatrics 23:3, 305-313
    CrossRef

  12. 12

    Vincenzo Salvo, Luc J. Zimmermann, Antonio W. Gavilanes, Ignazio Barberi, Alberto Ricotti, Raul Abella, Alessandro Frigiola, Alessandro Giamberti, Pasquale Florio, Paolo Tagliabue, Lucia G. Tina, Francesco Nigro, Francesca Temporini, Diego Gazzolo. (2011) First intention high-frequency oscillatory and conventional mechanical ventilation in premature infants without antenatal glucocorticoid prophylaxis. Pediatric Critical Care Medicine1
    CrossRef

  13. 13

    Anita S Bakshi. (2011) High Frequency Oscillatory Ventilation (HFOV) in Pediatrics. Apollo Medicine 8:1, 37-43
    CrossRef

  14. 14

    Waleed Maamoun, Amber E. Fort, James J. Cummings. 2011. Neonatal Respiratory Disease. , 590-608.
    CrossRef

  15. 15

    Michael J. Bell. 2011. Pediatric Neurocritical Care. , 741-745.
    CrossRef

  16. 16

    Naoya Iguchi, Osamu Hirao, Akinori Uchiyama, Takashi Mashimo, Masaji Nishimura, Yuji Fujino. (2010) Evaluation of performance of two high-frequency oscillatory ventilators using a model lung with a position sensor. Journal of Anesthesia 24:6, 888-892
    CrossRef

  17. 17

    Anton H. van Kaam, Peter C. Rimensberger, Dorine Borensztajn, Anne P. De Jaegere. (2010) Ventilation Practices in the Neonatal Intensive Care Unit: A Cross-Sectional Study. The Journal of Pediatrics 157:5, 767-771.e3
    CrossRef

  18. 18

    Walid Habre. (2010) Neonatal ventilation. Best Practice & Research Clinical Anaesthesiology 24:3, 353-364
    CrossRef

  19. 19

    Pierre Tissières, Patrick Myers, Maurice Beghetti, Michel Berner, Peter C. Rimensberger. (2010) Surfactant use based on the oxygenation response to lung recruitment during HFOV in VLBW infants. Intensive Care Medicine 36:7, 1164-1170
    CrossRef

  20. 20

    Robert H. Pfister, Jay P. Goldsmith. (2010) Quality Improvement in Respiratory Care: Decreasing Bronchopulmonary Dysplasia. Clinics in Perinatology 37:1, 273-293
    CrossRef

  21. 21

    Joshua M. Barnett, Susan E. Yanni, John S. Penn. (2010) The development of the rat model of retinopathy of prematurity. Documenta Ophthalmologica 120:1, 3-12
    CrossRef

  22. 22

    Matthew M. Laughon, P. Brian Smith, Carl Bose. (2009) Prevention of bronchopulmonary dysplasia. Seminars in Fetal and Neonatal Medicine 14:6, 374-382
    CrossRef

  23. 23

    Samir Gupta, Sunil K. Sinha, Steven M. Donn. (2009) Ventilatory management and bronchopulmonary dysplasia in preterm infants. Seminars in Fetal and Neonatal Medicine 14:6, 367-373
    CrossRef

  24. 24

    Jeffrey M. Perlman. (2009) The Relationship Between Systemic Hemodynamic Perturbations and Periventricular-Intraventricular Hemorrhage—A Historical Perspective. Seminars in Pediatric Neurology 16:4, 191-199
    CrossRef

  25. 25

    Anastasia Pellicano, David G. Tingay, John F. Mills, Stephen Fasulakis, Colin J. Morley, Peter A. Dargaville. (2009) Comparison of four methods of lung volume recruitment during high frequency oscillatory ventilation. Intensive Care Medicine 35:11, 1990-1998
    CrossRef

  26. 26

    Filip Cools, David J Henderson-Smart, Martin Offringa, Lisa M Askie, Filip Cools. 2009. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. .
    CrossRef

  27. 27

    S M Donn. (2009) Neonatal ventilators: how do they differ?. Journal of Perinatology 29, S73-S78
    CrossRef

  28. 28

    Koert de Waal, Nick Evans, Johanna van der Lee, Anton van Kaam. (2009) Effect of Lung Recruitment on Pulmonary, Systemic, and Ductal Blood Flow in Preterm Infants. The Journal of Pediatrics 154:5, 651-655
    CrossRef

  29. 29

    A.H. Morris, E. Hirshberg, K.A. Sward. (2009) Computer protocols: how to implement. Best Practice & Research Clinical Anaesthesiology 23:1, 51-67
    CrossRef

  30. 30

    Jong Jin Park, Pil Sang Lee, Sang Geel Lee. (2009) The effects of early surfactant treatment and minimal ventilation on prevention of bronchopulmonary dysplasia in respiratory distress syndrome. Korean Journal of Pediatrics 52:1, 44
    CrossRef

  31. 31

    Kushal Y. Bhakta, James M. Adams, Ann R. Stark. 2009. Chronic Lung Disease of Infancy. , 1-27.
    CrossRef

  32. 32

    Alice van Velzen, Anne De Jaegere, Johanna van der Lee, Anton van Kaam. (2009) Feasibility of weaning and direct extubation from open lung high-frequency ventilation in preterm infants. Pediatric Critical Care Medicine 10:1, 71-75
    CrossRef

  33. 33

    Tarah T Colaizy, Usama MM Younis, Edward F Bell, Jonathan M Klein. (2008) Nasal high-frequency ventilation for premature infants. Acta Paediatrica 97:11, 1518-1522
    CrossRef

  34. 34

    Andrea Milne. (2008) Summary of ‘Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants’. Evidence-Based Child Health: A Cochrane Review Journal 3:3, 809-810
    CrossRef

  35. 35

    DJ Henderson-Smart, F Cools, T Bhuta, M Offringa. (2008) Cochrane review: Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Evidence-Based Child Health: A Cochrane Review Journal 3:3, 731-808
    CrossRef

  36. 36

    Masakazu Miyawaki, Takahiro Okutani, Ryuzo Higuchi, Norishige Yoshikawa. (2008) The plasma angiotensin II level increases in very low-birth weight infants with neonatal chronic lung disease. Early Human Development 84:6, 375-379
    CrossRef

  37. 37

    Vibhuti S Shah, Prakesh S Shah. (2008) Promising new strategies for bronchopulmonary dysplasia in infants. Pediatric Health 2:3, 315-331
    CrossRef

  38. 38

    Niranjan Kissoon, Peter C. Rimensberger, Desmond Bohn. (2008) Ventilation Strategies and Adjunctive Therapy in Severe Lung Disease. Pediatric Clinics of North America 55:3, 709-733
    CrossRef

  39. 39

    Shawn M. Beck, David S. Finley, Geoffrey N. Box, Duane J. Vajgrt, Anne B. Wong, Debra E. Morrison, Nathan Kudrick, Elspeth M. McDougall, Ralph V. Clayman. (2008) High-Frequency Oscillatory Ventilatory Support During CT-Guided Percutaneous Cryotherapy of Renal Masses. Journal of Endourology 22:5, 923-926
    CrossRef

  40. 40

    ANNE GREENOUGH, MURALIDHAR PREMKUMAR, DEENA PATEL. (2008) Ventilatory strategies for the extremely premature infant. Pediatric Anesthesia 18:5, 371-377
    CrossRef

  41. 41

    R Ramanathan, S Sardesai. (2008) Lung protective ventilatory strategies in very low birth weight infants. Journal of Perinatology 28, S41-S46
    CrossRef

  42. 42

    Henry E. Fessler, David N. Hager, Roy G. Brower. (2008) Feasibility of very high-frequency ventilation in adults with acute respiratory distress syndrome*. Critical Care Medicine 36:4, 1043-1048
    CrossRef

  43. 43

    Laura Cerny, John S. Torday, Virender K. Rehan. (2008) Prevention and Treatment of Bronchopulmonary Dysplasia: Contemporary Status and Future Outlook. Lung 186:2, 75-89
    CrossRef

  44. 44

    Anne Greenough, Gabriel Dimitriou, Michael Prendergast, Anthony D Milner, Anne Greenough. 2008. Synchronized mechanical ventilation for respiratory support in newborn infants. .
    CrossRef

  45. 45

    Wendy J. Sturtz, Suzanne M. Touch, Robert G. Locke, Jay S. Greenspan, Thomas H. Shaffer. (2008) Assessment of neonatal ventilation during high-frequency oscillatory ventilation*. Pediatric Critical Care Medicine 9:1, 101-104
    CrossRef

  46. 46

    A.H.L.C. van Kaam. 2008. Neonatal Mechanical Ventilation. , 529-551.
    CrossRef

  47. 47

    Thomas E. Bachman, Norton E. Marks, Peter C. Rimensberger. (2008) Factors effecting adoption of new neonatal and pediatric respiratory technologies. Intensive Care Medicine 34:1, 174-178
    CrossRef

  48. 48

    Gerhard K. Wolf, John H. Arnold. (2008) A (large) step toward improved lung protection*. Pediatric Critical Care Medicine 9:1, 127-128
    CrossRef

  49. 49

    V Bhandari, R G Gavino, J H Nedrelow, P Pallela, A Salvador, R A Ehrenkranz, N L Brodsky. (2007) A randomized controlled trial of synchronized nasal intermittent positive pressure ventilation in RDS. Journal of Perinatology 27:11, 697-703
    CrossRef

  50. 50

    Anne Greenough, Atul Sharma. (2007) What is new in ventilation strategies for the neonate?. European Journal of Pediatrics 166:10, 991-996
    CrossRef

  51. 51

    Ralf M. Muellenbach, Markus Kredel, Harun M. Said, Bernd Klosterhalfen, Bernd Zollhoefer, Christian Wunder, Andreas Redel, Michael Schmidt, Norbert Roewer, Jörg Brederlau. (2007) High-frequency oscillatory ventilation reduces lung inflammation: a large-animal 24-h model of respiratory distress. Intensive Care Medicine 33:8, 1423-1433
    CrossRef

  52. 52

    David J Henderson-Smart, Filip Cools, Tushar Bhuta, Martin Offringa, David J Henderson-Smart. 2007. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. .
    CrossRef

  53. 53

    R. M. Muellenbach, C. Wunder, D. C. Nuechter, T. Smul, H. Trautner, M. Kredel, N. Roewer, J. Brederlau. (2007) Early treatment with arteriovenous extracorporeal lung assist and high-frequency oscillatory ventilation in a case of severe acute respiratory distress syndrome. Acta Anaesthesiologica Scandinavica 51:6, 766-769
    CrossRef

  54. 54

    Henry E. Fessler, Stephen Derdak, Niall D. Ferguson, David N. Hager, Robert M. Kacmarek, B Taylor Thompson, Roy G. Brower. (2007) A protocol for high-frequency oscillatory ventilation in adults: Results from a roundtable discussion*. Critical Care Medicine 35:7, 1649-1654
    CrossRef

  55. 55

    David Sweet, Giulio Bevilacqua, Virgilio Carnielli, Gorm Greisen, Richard Plavka, Ola Didrik Saugstad, Umberto Simeoni, Christian P. Speer, Adolf Valls-i-Soler, Henry Halliday. (2007) European consensus guidelines on the management of neonatal respiratory distress syndrome. Journal of Perinatal Medicine 35:3, 175-186
    CrossRef

  56. 56

    Gina Honey, Tammy Bleak, Tracy Karp, Amy MacRitchie, Donald Null .. (2007) Use of the Duotron Transporter High Frequency Ventilator During Neonatal Transport. Neonatal Network: The Journal of Neonatal Nursing 26:3, 167-174
    CrossRef

  57. 57

    Casper W. Bollen, Cuno S. P. M. Uiterwaal, Adrianus J. Vught. (2007) Meta-regression analysis of high-frequency ventilation vs conventional ventilation in infant respiratory distress syndrome. Intensive Care Medicine 33:4, 680-688
    CrossRef

  58. 58

    S Marret, L Marpeau, V Zupan-Simunek, D Eurin, C Lévêque, M-F Hellot, J Bénichou, . (2007) Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*. BJOG: An International Journal of Obstetrics & Gynaecology 114:3, 310-318
    CrossRef

  59. 59

    Anton H. van Kaam, Peter C. Rimensberger. (2007) Lung-protective ventilation strategies in neonatology: What do we know???What do we need to know?. Critical Care Medicine 35:3, 925-931
    CrossRef

  60. 60

    Stephen E. Lapinsky, Sangeeta Mehta. (2007) ARDS???Shake, rattle, and roll!*. Critical Care Medicine 35:1, 303-304
    CrossRef

  61. 61

    Mari??tte B. van Veenendaal, Anton H. van Kaam, Jack J. Haitsma, Ren?? Lutter, Burkhard Lachmann. (2006) Open lung ventilation preserves the response to delayed surfactant treatment in surfactant-deficient newborn piglets. Critical Care Medicine 34:11, 2827-2834
    CrossRef

  62. 62

    Casper W. Bollen, Cuno S. P. M. Uiterwaal, Adrianus J. van Vught, Ingeborg van der Tweel. (2006) Sequential Meta-analysis of Past Clinical Trials to Determine the Use of a New Trial. Epidemiology 17:6, 644-649
    CrossRef

  63. 63

    Carl D. Roosens, Ruggero Ama, H Alex Leather, Patrick Segers, Carlo Sorbara, Patrick F. Wouters, Jan I. Poelaert. (2006) Hemodynamic effects of different lung-protective ventilation strategies in closed chest pigs with normal lungs. Critical Care Medicine PAP,
    CrossRef

  64. 64

    Nejla Ben Jaballah, Ammar Khaldi, Khaled Mnif, Asma Bouziri, Sarra Belhadj, Asma Hamdi, Wassim Kchaou. (2006) High-frequency oscillatory ventilation in pediatric patients with acute respiratory failure. Pediatric Critical Care Medicine 7:4, 362-367
    CrossRef

  65. 65

    R F Soll. (2006) The clinical impact of high frequency ventilation: review of the cochrane meta-analyses. Journal of Perinatology 26, S38-S42
    CrossRef

  66. 66

    J. Bert Bunnell. 2006. High Frequency Ventilation. .
    CrossRef

  67. 67

    John P Kinsella, Anne Greenough, Steven H Abman. (2006) Bronchopulmonary dysplasia. The Lancet 367:9520, 1421-1431
    CrossRef

  68. 68

    P Jegatheesan, R L Keller, S Hawgood. (2006) Early variable-flow nasal continuous positive airway pressure in infants 1000 grams at birth. Journal of Perinatology 26:3, 189-196
    CrossRef

  69. 69

    Linda J. Van Marter. (2006) Progress in Discovery and Evaluation of Treatments to Prevent Bronchopulmonary Dysplasia. Biology of the Neonate 89:4, 303-312
    CrossRef

  70. 70

    Anne Greenough. (2006) High frequency oscillation and liquid ventilation. Paediatric Respiratory Reviews 7, S186-S188
    CrossRef

  71. 71

    Kay M. Tomashek, Chadd J. Crouse, Solomon Iyasu, Christopher H. Johnson, Lisa M. Flowers. (2006) A comparison of morbidity rates attributable to conditions originating in the perinatal period among newborns discharged from United States hospitals, 1989-90 and 1999-2000. Paediatric and Perinatal Epidemiology 20:1, 24-34
    CrossRef

  72. 72

    Anne Greenough, Atul Sharma. (2005) Optimal strategies for newborn ventilation—a synthesis of the evidence. Early Human Development 81:12, 957-964
    CrossRef

  73. 73

    Marcos F. Vidal Melo. (2005) Clinical Respiratory Physiology of the Neonate and Infant With Congenital Heart Disease. International Anesthesiology Clinics 42:4, 29-43
    CrossRef

  74. 74

    Hannes Rieger, Stefan Kuhle, Osman S. Ipsiroglu, Harald Heinzl, Christian N. Popow. (2005) Effects of open vs. closed system endotracheal suctioning on cerebral blood flow velocities in mechanically ventilated extremely low birth weight infants. Journal of Perinatal Medicine 33:5, 435-441
    CrossRef

  75. 75

    Shetal I. Shah. (2005) Viewpoint:. Academic Medicine 80:5, 452-454
    CrossRef

  76. 76

    Linda J Van Marter. (2005) Strategies for preventing bronchopulmonary dysplasia. Current Opinion in Pediatrics 17:2, 174-180
    CrossRef

  77. 77

    Alison B. Froese, John P. Kinsella. (2005) High-frequency oscillatory ventilation: Lessons from the neonatal/pediatric experience. Critical Care Medicine 33:Supplement, S115-S121
    CrossRef

  78. 78

    Henry E. Fessler, Roy G. Brower. (2005) Protocols for lung protective ventilation. Critical Care Medicine 33:Supplement, S223-S227
    CrossRef

  79. 79

    Michelle Duggan, Doreen Engelberts, Robert P. Jankov, Jordan M. A. Worrall, Rong Qu, Gregory M. T. Hare, A. Keith Tanswell, J. Brendan Mullen, Brian P. Kavanagh. (2005) Hypocapnia attenuates mesenteric ischemia-reperfusion injury in a rat model. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 52:3, 262-268
    CrossRef

  80. 80

    Giovanni Vento, Piero G. Matassa, Franco Ameglio, Ettore Capoluongo, Enrico Zecca, Luca Tortorolo, Mara Martelli, Costantino Romagnoli. (2005) HFOV in premature neonates: effects on pulmonary mechanics and epithelial lining fluid cytokines. A randomized controlled trial. Intensive Care Medicine 31:3, 463-470
    CrossRef

  81. 81

    Thomas N. Hansen, Anthony Corbet, Alfred L. Gest, Alicia A. Moise. 2005. Principles of Respiratory Monitoring and Therapy. , 648-669.
    CrossRef

  82. 82

    Beverly A. Banks-Randall, Roberta A. Ballard. 2005. Bronchopulmonary Dysplasia. , 723-736.
    CrossRef

  83. 83

    Eric C. Eichenwald. 2005. Care of the Extremely Low-Birth-Weight Infant. , 410-426.
    CrossRef

  84. 84

    Young Don Kim, Ellen Ai-Rhan Kim, Ki-Soo Kim, Soo-Young Pi, Weechang Kang. (2005) Scoring Method for Early Prediction of Neonatal Chronic Lung Disease Using Modified Respiratory Parameters. Journal of Korean Medical Science 20:3, 397
    CrossRef

  85. 85

    Kathleen M. Ventre, John H. Arnold. (2004) High frequency oscillatory ventilation in acute respiratory failure. Paediatric Respiratory Reviews 5:4, 323-332
    CrossRef

  86. 86

    A Greenough, AD Milner, G Dimitriou, Anne Greenough. 2004. Synchronized mechanical ventilation for respiratory support in newborn infants. .
    CrossRef

  87. 87

    Jean-Christophe Bouchut, Jean Godard, Olivier Claris. (2004) High-frequency Oscillatory Ventilation. Anesthesiology 100:4, 1007-1012
    CrossRef

  88. 88

    KATHARINA VON DER HARDT, MICHAEL ANDREAS KANDLER, LUDGER FINK, ELLEN SCHOOF, J??RG D??TSCH, OLGA BRANDENSTEIN, RAINER MARIA BOHLE, WOLFGANG RASCHER. (2004) High Frequency Oscillatory Ventilation Suppresses Inflammatory Response in Lung Tissue and Microdissected Alveolar Macrophages in Surfactant Depleted Piglets. Pediatric Research 55:2, 339-346
    CrossRef

  89. 89

    Carl T D???Angio, William M Maniscalco. (2004) Bronchopulmonary Dysplasia in Preterm Infants. Pediatric Drugs 6:5, 303-330
    CrossRef

  90. 90

    PAK CHEUNG NG, ALVIN KWAN HO KWOK, CHEUK HON LEE, BARBARA SAU MAN TAM, CHRISTOPHER WAI KEI LAM, KWOK CHIU MA, IRIS HIU SHUEN CHAN, ERIC WONG, DENNIS SHUN CHIU LAM, TAI FAI FOK. (2004) Early Pituitary-Adrenal Responses and Retinopathy of Prematurity in Very Low Birth Weight Infants. Pediatric Research 55:1, 114-119
    CrossRef

  91. 91

    Marya Strand, Alan H Jobe. (2003) The multiple negative randomized controlled trials in perinatology—why?. Seminars in Perinatology 27:4, 343-350
    CrossRef

  92. 92

    Reinout J. Mildner, Helena Frndova, Peter N. Cox. (2003) Effect of air and heliox as carrier gas on CO2 transport in a model of high-frequency oscillation comparing two oscillators. Critical Care Medicine 31:6, 1759-1763
    CrossRef

  93. 93

    (2003) High-Frequency Ventilation. New England Journal of Medicine 348:12, 1181-1182
    Full Text

  94. 94

    Jeffrey M. Singh, Thomas E. Stewart. (2003) High-frequency oscillatory ventilation in adults with acute respiratory distress syndrome. Current Opinion in Critical Care 9:1, 28-32
    CrossRef

  95. 95

    Prakesh S Shah. (2003) Current Perspectives on the Prevention and Management of Chronic Lung Disease in Preterm Infants. Pediatric Drugs 5:7, 463-480
    CrossRef

  96. 96

    P. Friedlich, N. Subramanian, M. Sebald, S. Noori, I. Seri. (2003) Use of high-frequency jet ventilation in neonates with hypoxemia refractory to high-frequency oscillatory ventilation. Journal of Maternal-Fetal and Neonatal Medicine 13:6, 398-402
    CrossRef

  97. 97

    Stark, Ann R., . (2002) High-Frequency Oscillatory Ventilation to Prevent Bronchopulmonary Dysplasia — Are We There Yet?. New England Journal of Medicine 347:9, 682-684
    Full Text

  98. 98

    Slutsky, Arthur S., , Drazen, Jeffrey M., . (2002) Ventilation with Small Tidal Volumes. New England Journal of Medicine 347:9, 630-631
    Full Text

Letters